Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-24,969
Closed -$2.77M 645
2022
Q4
$2.77M Buy
+24,969
New +$2.55M 0.29% 51
2020
Q4
Sell
-12,975
Closed -$1.03M 490
2020
Q3
$1.03M Buy
+12,975
New +$1.02M 0.17% 88
2019
Q4
Sell
-4,349
Closed -$349K 544
2019
Q3
$349K Buy
+4,349
New +$349K 0.09% 170

Other funds holding MRK

Cowen and Company's MRK Position: Q1 2023 in Review

Cowen and Company sold out of Merck (MRK) in Q1 2023, closing a stake of 24,969 shares — an estimated $2.77M sold.

Cowen and Company first reported a position in MRK in Q3 2019 and held it in 3 quarters. The position peaked at $2.77M in Q4 2022. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Cowen and Company reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 24,969 Merck shares in Q1 2023, an estimated $2.77M.
  • Cowen and Company first reported a position in Merck in Q3 2019 and held it in 3 quarters.
  • Cowen and Company's Merck position peaked at $2.77M in Q4 2022.
  • 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.